CAS: 1610833-03-8
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Burosumab REF: TM-T77455CAS: 1610833-03-8 | SDS-PAGE:98.4%;SEC-HPLC:97.9% | 198.00 €~745.00 € | Mon 02 Dec 24 |
 | Burosumab REF: 3D-CLA1443CAS: 1610833-03-8 | - - - | To inquire | Tue 10 Dec 24 |
Burosumab
CAS:1610833-03-8
Burosumab (KRN23), a human monoclonal antibody, treats CSHS and tumor-induced osteochondrosis by targeting FGF23.
Purity:
SDS-PAGE:98.4%;SEC-HPLC:97.9%
Color and Shape:
Liquid
Molecular weight:
144.08 kDa
Ref: TM-T77455
| 1mg | 198.00 € | ||
| 5mg | 462.00 € | ||
| 10mg | 745.00 € |
Estimated delivery in United States, on Monday 2 Dec 2024
Ref: 3D-CLA1443
| Undefined size | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
